Mohsen Tafaghodi - Nanotechnology

Author Information

Mohsen Tafaghodi is affiliated with the School of Pharmacy and the Nanotechnology Research Center at the Pharmaceutical Technology Institute, both part of Mashhad University of Medical Sciences, located in Mashhad, Iran. His research primarily focuses on the intersection of nanotechnology and pharmaceutical sciences, particularly in the development of innovative drug delivery systems.

Research Contributions

Mohsen Tafaghodi has made significant contributions to the field of nanotechnology and pharmaceutical sciences. His research includes the development of novel drug delivery systems such as B12-functionalized PEGylated liposomes for oral insulin delivery, inhalable dry powders for pulmonary delivery of peptides and proteins, and various nano-adjuvant systems for enhancing the immunogenicity of vaccines. His work also extends to the development of intelligent packaging materials and the synthesis of nanoparticles with therapeutic properties. Tafaghodi's research has been published in reputed journals, contributing valuable insights into the mechanisms and applications of nanotechnology in medicine.

Aliases

Mohsen Tafaghodi is also known by the aliases M Tafaghodi and M. Tafaghodi.

Publication and Citation Metrics

Metric	Value
Citation Count	2773
h-index	31
Paper Count	125

Publications:

B12-functionalized PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies

DOI: 10.1016/j.jddst.2022.103141

Year: 2022

Evaluation of various techniques for production of inhalable dry powders for pulmonary delivery of peptide and protein

DOI: 10.1016/j.jddst.2022.103186

Year: 2022

T helper type 1 biased immune responses by PPE17 loaded core-shell alginate-chitosan nanoparticles after subcutaneous and intranasal administration.

DOI: 10.1016/j.lfs.2021.119806

Year: 2021

Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis.

DOI: 10.1208/s12249-021-02146-z

Year: 2021

Prunus armeniaca gum exudates: An overview on purification, structure, physicochemical properties, and applications

DOI: 10.1002/fsn3.2107

Year: 2021

pH‐sensitive soluble soybean polysaccharide/SiO2 incorporated with curcumin for intelligent packaging applications

DOI: 10.1002/fsn3.2187

Year: 2021

Enhancement of the immunogenicity of a Mycobacterium tuberculosis fusion protein using ISCOMATRIX and PLUSCOM nano-adjuvants after nasal administration in mice

DOI: 10.1101/2021.08.27.458002

Year: 2021

The dry powder formulation of mixed cross-linked dextran microspheres and tetanus toxoid-loaded trimethyl chitosan nanospheres as a potent adjuvant for nasal delivery system

DOI: 10.22038/ijbms.2020.49486.11313

Year: 2021

Immunogenicity of HspX/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model.

DOI: 10.1016/j.micpath.2021.104842

Year: 2021

Development of curcumin‐loaded Prunus armeniaca gum nanoparticles: Synthesis, characterization, control release behavior, and evaluation of anticancer and antimicrobial properties

DOI: 10.1002/fsn3.2562

Year: 2021

Why are legal fees significant in Nanotechnology?

What is Diameter in Nanotechnology?

How Can Interested Parties Get Involved?

Can Nanotechnology Help Treat Respiratory Diseases?

What are Composite Nanoadsorbents?

What Does High Surface Area to Volume Ratio Mean?

How Do Nanomaterials Achieve Lightweight and Strength?

How are Environmental Tests Conducted?

Why are Nanoclusters Important?

How Does Particulate Fouling Occur?

Partnered Content Networks

Relevant Topics